Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Growth hormone treatment induces mammary gland hyperplasia in aging primates

Abstract

The decline of growth hormone (GH) and insulin-like growth factor I (ICF-I) production during aging has been likened to the decrease in gonadal steroids in menopause. The repletion of GH/IGF-I levels in aging individuals is suggested to restore the lean tissue anabolism characteristic of youth1. In addition to anabolic effects on musculoskeletal tissues, GH also stimulates mammary glandular growth in some species2–4, although its effects on primate mammary growth remain unclear5. Some clinical observations implicate GH in human mammary growth, for example, gynecomastia occurs in some children treated with GH (ref. 6), and tall stature and acromegaly are associated with an increased incidence of breast cancer7,8. To investigate the effects of GH/IGF-I augmentation on mammary tissue in a model relevant to aging humans, we treated aged female rhesus monkeys with GH, IGF-I, GH + IGF-I or saline diluent for 7 weeks. IGF-I treatment was associated with a twofold increase, GH with a three- to fourfold increase, and GH + IGF-I with a four- to fivefold increase in mammary glandular size and epithelial proliferation index. These mitogenic effects were directly correlated with circulating GH and IGF-I levels, suggesting that either GH or its downstream effector IGF-I stimulates primate mammary epithelial proliferation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Rudman, D. et al. Effects of human growth hormone in men over 60 years old. N. Engl. J. Med. 323, 1–6 (1990).

    Article  CAS  Google Scholar 

  2. Forsyth, I.A. The mammary gland. Baillieres Clin. Endocrinol. Metab. 5, 809–832 (1991).

    Article  CAS  Google Scholar 

  3. Kleinberg, D.L., Ruan, W., Catanese, V., Newman, C.B. & Feldman, M. Non-lactogenic effects of growth hormone on growth and insulin-like growth factor-l messenger ribonucleic acid of rat mammary gland. Endocrinology 126, 3274–3276 (1990).

    Article  CAS  Google Scholar 

  4. Plaut, K., Ikeda, M. & Vonderhaar, B.K. Role of growth hormone and insulin-like growth factor-l in mammary development. Endocrinology 133, 1843–1848 (1993).

    Article  CAS  Google Scholar 

  5. Kleinberg, D.L. et al. Primate mammary development: Effects of hypophysectomy, prolactin inhibition, and growth hormone administration. J. Clin. Invest. 75, 1943–1950 (1985).

    Article  CAS  Google Scholar 

  6. Malozowski, S. & Stadel, B.V. Prepubertal gynecomastia during growth hormone therapy. J. Pediatr. 126, 659–661 (1995).

    Article  CAS  Google Scholar 

  7. Hunter, D.J. & Willett, W.C., Diet, body size, and breast cancer. Epidemiol. Rev. 15, 110–132 (1993).

    Article  CAS  Google Scholar 

  8. Nabarro, J.D., Clin. Endocrinol. (Oxf) 26, 481–512 (1987).

    Article  CAS  Google Scholar 

  9. LeRoith, D. et al. The effects of growth hormone and insulin-like growth factor I on the immune system of aged female monkeys. Endocrinology 137, 1071–1079 (1996).

    Article  CAS  Google Scholar 

  10. Cerdes, J., Schwab, U., Lemke, H. & Stein, H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer 31, 13–20 (1983).

    Article  Google Scholar 

  11. Kelly, P.A. et al. The growth hormone/prolactin receptor family. Recent Prog. Harm. Res. 48, 123–164 (1993).

    Article  CAS  Google Scholar 

  12. Djiane, J., Houdebine, L.M. & Kelly, P.A. Prolactin-like activity of anti-prolactin receptor antibodies on casein and DNA synthesis in the mammary gland. Proc. Natl. Acad. Sci. USA 78, 7445–7448 (1981).

    Article  CAS  Google Scholar 

  13. Fuh, G. & Wells, J.A. Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines. J. Biol. Chem. 270, 13133–13137 (1995).

    Article  CAS  Google Scholar 

  14. Martinez, A.J. Prolactin and carcinoma of the breast. Mayo Clin. Proc. 67, 1011–1012 (1992).

    Article  CAS  Google Scholar 

  15. Bondy, C.A. et al. Clinical uses of insulin-like growth factor-l. Ann. Intern. Med. 120, 593–601 (1994).

    Article  CAS  Google Scholar 

  16. Yee, D. et al. Analysis of insulin-like growth factor I gene expression in malignancy: Evidence for a paracrine role in human breast cancer. Mol. Endocrinol. 3, 509–517 (1989).

    Article  CAS  Google Scholar 

  17. Neuenschwander, S. et al. Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model. J. Clin. Invest. 97, 2225–2232 (1996).

    Article  CAS  Google Scholar 

  18. Hadseli, D.L., Greenberg, N.M., Fligger, J.M., Baumrucker, C.R. & Rosen, J.M. Targeted expression of des (1-3) human insulin-like growth factor I in transgenic mice influences mammary gland development and IGF-binding protein expression. Endocrinology 137, 321–330 (1996).

    Article  Google Scholar 

  19. Adesanya, O.O., Zhou, J. & Bondy, C.A. Sex steroid regulation of insulin-like growth factor system gene expression and proliferation in primate myometrium. J. Clin. Endocrinol. Metab. 81, 1967–1974 (1996).

    CAS  PubMed  Google Scholar 

  20. Lee, A.V. & Yee, D. Insulin-like growth factors and breast cancer. Biomed. Pharmacother. 49, 415–421 (1995).

    Article  CAS  Google Scholar 

  21. Baum, H.B. et al. Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. Ann. Intern. Med. 125, 883–890 (1996).

    Article  CAS  Google Scholar 

  22. Toogood, A.A., Adams, J.E., O'Neill, P.A. & Shalet, S.M. Elderly patients with adult-onset growth hormone deficiency are not osteopenic. J. Clin. Endocrinol. Metab. 82, 1462–1466 (1997).

    CAS  PubMed  Google Scholar 

  23. Mulligan, K., Grunfelf, C., Hellerstein, M.K., Neese, R.A., & Schambelan, M., Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. J. Clin. Endocrinol. Metab. 77, 956–962 (1993).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ng, S., Zhou, J., Adesanya, O. et al. Growth hormone treatment induces mammary gland hyperplasia in aging primates. Nat Med 3, 1141–1144 (1997). https://doi.org/10.1038/nm1097-1141

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1097-1141

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing